Clinical trial
Expanded Dryvax Dilution Study in Previously Vaccinated Adults
NCT00050505 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00050505 |
|---|---|
| Title | Expanded Dryvax Dilution Study in Previously Vaccinated Adults |
| Official title | A Multicenter, Double Blind, Randomized Dose-response Study of Dryvax Vaccine Against Smallpox in Previously Vaccinated Adults |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Smallpox |
| Intervention type | Biological |
| Interventions | Live vaccinia virus vaccine |
| Enrollment | 927 |
| Start date | Oct 1, 2002 |
| Completion | Dec 1, 2003 |
| First posted | Dec 11, 2002 |
| Last update posted | Dec 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: